Domain > briumvi.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2024-04-13	172.67.71.72 (ClassC)
2024-12-01	104.26.8.235 (ClassC)
2024-12-18	104.26.9.235 (ClassC)
2025-02-09	172.66.46.214 (ClassC)
2025-04-20	172.66.45.42 (ClassC)
2026-02-12	172.66.43.82 (ClassC)

HTTP/1.1 200 OKDate: Mon, 27 Nov 2023 00:16:19 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveCF-Ray: 82c62e8998666810-SEACF-Cache-Status: HITAge: 526266Cache-

!DOCTYPE html>html classno-js langen-US>head>script>(function(w,d,s,l,i){wlwl||;wl.push({gtm.start:new Date().getTime(),event:gtm.js});var fd.getElementsByTagName(s)0,jd.createElement(s),dll!dataLayer?&l+l:;j.asynctrue;j.srchttps://www.googletagmanager.com/gtm.js?id+i+dl;f.parentNode.insertBefore(j,f);})(window,document,script,dataLayer,GTM-NDH4WJ9);/script> script async srchttps://www.googletagmanager.com/gtag/js?idG-949Q13QV5K>/script> script> window.dataLayer  window.dataLayer || ; function gtag(){dataLayer.push(arguments);} gtag(js, new Date()); gtag(config, G-949Q13QV5K); /script>meta charsetUTF-8>meta nameviewport contentwidthdevice-width, initial-scale1.0>link relpreload hrefhttps://briumvi.com/wp-content/uploads/typolab-fonts/google/lato-cd4b8/s6uyw4bmutphjx4wxiwtfcc.woff2 asfont typefont/woff2 crossorigin>link relpreload hrefhttps://briumvi.com/wp-content/uploads/typolab-fonts/google/lato-cd4b8/s6u9w4bmutphh6uvswipgq3q5d0.woff2 asfont typefont/woff2 crossorigin>link relpreload hrefhttps://briumvi.com/wp-content/uploads/typolab-fonts/google/lato-cd4b8/s6u9w4bmutphh50xswipgq3q5d0.woff2 asfont typefont/woff2 crossorigin>meta namerobots contentindex, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1 />title>BRIUMVI ® (ublituximab-xiiy)/title>meta namedescription contentBRIUMVI ® (ublituximab-xiiy) is available for people with relapsing multiple sclerosis (RMS), the only B-cell therapy for RMS that is administered in 1 hour, twice per year. />link relcanonical hrefhttps://briumvi.com/ />meta propertyog:locale contenten_US />meta propertyog:type contentwebsite />meta propertyog:title contentBRIUMVI ® (ublituximab-xiiy) />meta propertyog:description contentBRIUMVI ® (ublituximab-xiiy) is available for people with relapsing multiple sclerosis (RMS), the only B-cell therapy for RMS that is administered in 1 hour, twice per year. />meta propertyog:url contenthttps://briumvi.com/ />meta propertyog:site_name contentBRIUMVI® (ublituximab-xiiy) />meta propertyarticle:modified_time content2023-

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > briumvi.com

Is this malicious?

DNS Resolutions

Port 443